Ultrabright fluorescent mesoporous silica nanoparticles for prescreening of cervical cancer

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 9, Issue 8, 2013, Pages 1255-1262

  Palantavida, Shajesh ^a   Guz, Nataliia V ^a   Woodworth, C D ^b   Sokolov, I ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b CLARKSON UNIVERSITY   (United States)

Author keywords

Cervical cancer; Early cancer detection; Fluorescent silica particles; Novel detection methods; Pap smear liquid cytology tests

Indexed keywords

CERVICAL CANCERS; DETECTION METHODS; EARLY CANCER DETECTION; PAP SMEAR; SILICA PARTICLES;

CELL CULTURE; DISEASES; FLUORESCENCE; ORGANIC ACIDS; TESTING;

CELLS;

FOLIC ACID; NANOPARTICLE; SILICON DIOXIDE; ULTRABRIGHT FLUORESCENT MESOPOROUS SILICA NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER SCREENING; CASE REPORT; CELL IMMORTALIZATION; CELL ISOLATION; CELL LABELING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA VIRUS; FEMALE; HUMAN; HUMAN CELL; INCUBATION TIME; PAPILLOMA VIRUS; PRECANCER; RELIABILITY; UTERINE CERVIX CANCER;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

CERVICAL CANCER; EARLY CANCER DETECTION; FLUORESCENT SILICA PARTICLES; NOVEL DETECTION METHODS; PAP SMEAR/LIQUID CYTOLOGY TESTS;

CERVIX UTERI; EARLY DETECTION OF CANCER; FEMALE; FLUORESCENT DYES; FOLIC ACID; HUMANS; NANOPARTICLES; POROSITY; SILICON DIOXIDE; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 84886397954     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.04.011     Document Type: Article

References (49)

1. Walboomers J.M.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
2. Nuovo J., Melnikow J., Howell L.P. New tests for cervical cancer screening. Am Fam Physician 2001, 64:780-786.
3. Mitchell M.F., Cantor S.B., Ramanujam N., Tortolero-Luna G., Richards-Kortum R. Fluorescence spectroscopy for diagnosis of squamous intraepithelial lesions of the cervix. Obstet Gynecol 1999, 93:462-470.
4. Monsonego J., Bosch F.X., Coursaget P., Cox J.T., Franco E., Frazer I., et al. Cervical cancer control, priorities and new directions. Int J Cancer 2004, 108:329-333.
5. Katki H.A., Wentzensen N. How might HPV testing be integrated into cervical screening?. Lancet Oncol 2012, 13:8-10.
6. Belinson J.L., Pretorius R.G., Zhang W.H., Wu L.Y., Qiao Y.L., Elson P. Cervical cancer screening by simple visual inspection after acetic acid. Obstet Gynecol 2001, 98:441-444.
7. Bhatla N., Mukhopadhyay A., Joshi S., Kumar A., Kriplani A., Pandey R.M., et al. Visual inspection for cervical cancer screening: Evaluation by doctor versus paramedical worker. Indian J Cancer 2004, 41:32-36.
8. Drezek R.A., Collier T., Brookner C.K., Malpica A., Lotan R., Richards-Kortum R.R., et al. Laser scanning confocal microscopy of cervical tissue before and after application of acetic acid. Am J Obstet Gynecol 2000, 182:1135-1139.
9. Pitris C., Goodman A., Boppart S.A., Libus J.J., Fujimoto J.G., Brezinski M.E. High-resolution imaging of gynecologic neoplasms using optical coherence tomography. Obstet Gynecol 1999, 93:135-139.
10. Iyer K.S., Gaikwad R.M., Woodworth C.D., Volkov D.O., Sokolov I. Physical labeling of papillomavirus-infected, immortal, and cancerous cervical epithelial cells with fluorescent silica beads. Cell Biochem Biophys 2012, 63:109-116.
11. Iyer S., Woodworth C.D., Gaikwad R.M., Kievsky Y.Y., Sokolov I. Towards nonspecific detection of malignant cervical cells with fluorescent silica beads. Small 2009, 5:2277-2284.
12. Low P.S., Henne W.A., Doorneweerd D.D. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res 2007, 41:120-129.
13. Sittig C., Hahner G., Marti A., Textor M., Spencer N.D., Hauert R. The implant material, ti6al7nb: Surface microstructure, composition and properties. J Mater Sci Mater Med 1999, 10:191-198.
14. Santra S., Liesenfeld B., Dutta D., Chatel D., Batich C.D., Tan W., et al. Folate conjugated fluorescent silica nanoparticles for labeling neoplastic cells. J Nanosci Nanotechnol 2005, 5:899-904.
15. Zhang H.W., Sun Z.G., Zhang S.Y., Han B.S., Shen B.G., Tung I.C., et al. Intergrain exchange coupling and coercivity mechanism of nanocrystalline sm2fe15-xcuxsi2c (x=0 and 1) ribbons prepared by melt spinning. Phys Rev B 1999, 60:64-67.
16. Landmark K.J., Dimaggio S., Ward J., Kelly C., Vogt S., Hong S., et al. Synthesis, characterization, and in vitro testing of superparamagnetic iron oxide nanoparticles targeted using folic acid-conjugated dendrimers. ACS Nano 2008, 2:773-783.
17. Wang Y., Xu J., Xia X., Yang M., Vangveravong S., Chen J., et al. Sv119-gold nanocage conjugates: A new platform for targeting cancer cells via sigma-2 receptors. Nanoscale 2012, 4:421-424.
18. Benezra M., Penate-Medina O., Zanzonico P.B., Schaer D., Ow H., Burns A., et al. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Invest 2011, 121:2768-2780.
19. Wang S., Low P.S. Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. J. Controlled Release 1998, 53:39-48.
20. Low P.S., Antony A.C. Folate receptor-targeted drugs for cancer and inflammatory diseases. Adv Drug Deliv Rev 2004, 56:1055-1058.
21. Sun C., Sze R., Zhang M. Folic acid-peg conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. J Biomed Mater Res A 2006, 78A:550-557.
22. Rosenholm J.M., Meinander A., Peuhu E., Niemi R., Eriksson J.E., Sahlgren C., et al. Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano 2009, 3:197-206.
23. Lavi Y., Gov N., Edidin M., Gheber L.A. Lifetime of major histocompatibility complex class-i membrane clusters is controlled by the actin cytoskeleton. Biophys J 2012, 102:1543-1550.
24. Boyle S., Kolin D.L., Bieler J.G., Schneck J.P., Wiseman P.W., Edidin M. Quantum dot fluorescence characterizes the nanoscale organization of t cell receptors for antigen. Biophys J 2011, 101:L57-L59.
25. Sokolov I., Naik S. Novel fluorescent silica nanoparticles: Towards ultrabright silica nanoparticles. Small 2008, 4:934-939.
26. Sokolov I., Kievsky Y.Y., Kaszpurenko J.M. Self-assembly of ultrabright fluorescent silica particles. Small 2007, 3:419-423.
27. Cho E.-B., Volkov D.O., Sokolov I. Ultrabright fluorescent silica mesoporous silica nanoparticles: Control of particle size and dye loading. Adv Funct Mater 2011, 21:3129-3135.
28. Vallant T., Brunner H., Mayer U., Hoffmann H., Leitner T., Resch R., et al. Formation of self-assembled octadecylsiloxane monolayers on mica and silicon surfaces studied by atomic force microscopy and infrared spectroscopy. J Phys Chem B 1998, 102:7190-7197.
29. Palantavida S, Guz NV, Sokolov I. Functionalized ultrabright fluorescent mesoporous silica nanoparticles. Part Part Syst Charact. http://dx.doi.org/10.1002/ppsc.201300143 (in press).
30. Jaetao J.E., Butler K.S., Adolphi N.L., Lovato D.M., Bryant H.C., Rabinowitz I., et al. Enhanced leukemia cell detection using a novel magnetic needle and nanoparticles. Cancer Res 2009, 69:8310-8316.
31. Sanborn W.R., Heuck C.C., El Aouad R., Storch W.B. Fluorescence microscopy for disease diagnosis and environmental monitoring 2005, World Health Organization. Regional Office for the Eastern Mediterranean, Cairo.
32. Wright T.C., Ronnett B.M., Kurman R.J., Ferenczy A. Precancerous lesions of the cervix. Blaustein's pathology of the female genital tract 1994, 193-252. Springer-Verlag, New York. R.J. Kurman (Ed.).
33. Song S., Liem A., Miller J.A., Lambert P.F. Human papillomavirus types 16 e6 and e7 contribute differently to carcinogenesis. Virology 2000, 267:141-150.
34. Woodworth C.D., Doniger J., Dipaolo J.A. Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. J Virol 1989, 63:159-164.
35. Woodworth C.D., Waggoner S., Barnes W., Stoler M.H., Dipaolo J.A. Human cervical and foreskin epithelial cells immortalized by human papillomavirus DNAs exhibit dysplastic differentiation in vivo. Cancer Res 1990, 50:3709-3715.
36. Woodworth C.D., Mcmullin E., Iglesias M., Plowman G.D. Interleukin-1-alpha and tumor-necrosis-factor-alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial-cells. Proc Nat Acad Sci USA 1995, 92:2840-2844.
37. Cho E.-B., Volkov D.O., Sokolov I. Ultrabright fluorescent silica mesoporous silica nanoparticles: Control of particle size and dye loading. Adv Funct Mater 2011, 21:3129-3135.
38. Cho E.B., Volkov D.O., Sokolov I. Ultrabright fluorescent mesoporous silica nanoparticles. Small 2010, 6:2314-2319.
39. Chithrani B.D., Ghazani A.A., Chan W.C.W. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006, 6:662-668.
40. Samuels M.L., Witmer J.A. Statistics for the life sciences 1999, Prentice Hall, Inc., New Jersey.
41. Zou K.H., Hall W.J., Shapiro D.E. Smooth non-parametric receiver operating characteristic (roc) curves for continuous diagnostic tests. Stat Med 1997, 16:2143-2156.
42. Seong Ho Park J.M.G., Jo Chan-Hee Receiver operating characteristic (roc) curve: Practical review for radiologists. Korean J Radiol 2004, 5:11-18.
43. Karpov I., Belcher R.W., Linn J.H. Electric force microscopy as a probe of active and passive elements of integrated circuits. Appl Surf Sci 1998, 125:332-338.
44. Abe M., Sugawara Y., Sawada K., Andoh Y., Morita S. Near-field optical imaging using force detection with new tip-electrode geometry. Appl Surf Sci 1999, 140:383-387.
45. Noel T., Franceschi S., Perez E., Vicendo P., Rico-Lattes I. High compacted DNA-polymer complexes via new polynorbornene polycationic latexes with acetate counterion. Langmuir 2000, 16:8980-8983.
46. Vallhov H., Gabrielsson S., Strømme M., Scheynius A., Garcia-Bennett A.E. Mesoporous silica particles induce size dependent effects on human dendritic cells. Nano Lett 2007, 7:3576-3582.
47. Rejman J., Oberle V., Zuhorn I.S., Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin and caveolae-mediated endocytosis. Biochem J 2004, 377:159-169.
48. Nanda K., Mccrory D.C., Myers E.R., Bastian L.A., Hasselblad V., Hickey J.D., et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Intern Med 2000, 132:810-819.
49. Kuhn L., Denny L., Pollack A., Lorincz A., Richart R.M., Wright T.C. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst 2000, 92:818-825.